Therapy News and Research

RSS

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025.

From Bruker Cellular Analysis 25 Apr 2025

Serum hsa_circ_101555 as a promising biomarker for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking. Circular RNAs (circRNAs) are one of the promising biomarkers.

24 Apr 2025

Novel cancer immunotherapy approach could complement existing CAR-T treatments

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

24 Apr 2025

AI tools improve detection of key immune structures in melanoma

Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary lymphoid structures (TLS) in thousands of digital images of melanoma tumor tissue, significantly enhancing TLS identification and survival predictions for operable stage III/IV patients.

24 Apr 2025

lncRNAs shape the tumor microenvironment and drive cancer development

The tumor microenvironment (TME) is a complex and dynamic network consisting of tumor cells, immune cells, stromal cells, extracellular matrix (ECM), cytokines, and growth factors, all interacting to influence tumorigenesis, progression, and metastasis.

24 Apr 2025

Manipulating a master regulator prevents tumor growth in mice

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, critical role in dampening the immune system's response to cancer.

24 Apr 2025

Surgery may not be necessary for some early-stage breast cancer patients

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment, according to new data from researchers at The University of Texas MD Anderson Cancer Center.

24 Apr 2025

Prostate cancer diagnosis is not a death sentence, study says

Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022.

24 Apr 2025

Rethinking stroke prevention for patients with mild carotid narrowing

Ischemic stroke remains one of the leading causes of death and long-term disability worldwide, with narrowing of the carotid artery due to atherosclerosis contributing to up to 30% of all cases.

24 Apr 2025

Neutrophil subpopulations could help predict autoimmune disease relapse

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, these cells are also active in autoimmune diseases.

24 Apr 2025

Novel technology for in situ irradiation of tumors

Radiation therapy is an established method of cancer treatment. It works by subjecting tumor cells to ionizing radiation, damaging their genetic material and, ideally, eliminating the tumor.

24 Apr 2025

Exploring the role of immune checkpoints IDO1 and PDL1 in Cutaneous Leishmaniasis (CL)

Explore how immune checkpoints IDO1 and PDL1 influence the immune response in Cutaneous Leishmaniasis (CL).

From TissueGnostics 24 Apr 2025

New compound shows promise in treating hard-to-treat inflammatory conditions

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions.

24 Apr 2025

New antibiotic offers hope for more effective Lyme disease treatment

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, impacts nearly half a million individuals in the U.S. annually.

24 Apr 2025

Step-and-shoot proton arc therapy reduces cancer treatment side effects

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment has proven effective at eliminating a hard-to-treat cancer with the only side effect being light skin discoloration, even nine months after treatment.

24 Apr 2025

New research moves toward personalized treatment for depression

Depression involves a complex interplay of psychological patterns, biological vulnerabilities and social stressors, making its causes and symptoms highly variable.

23 Apr 2025

Scientists uncover why Lyme disease symptoms may linger after treatment

Symptoms that persist long after Lyme disease is treated are not uncommon - a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop Post Treatment Lyme Disease (PTLD).

23 Apr 2025

Scientists unlock secrets of how cells navigate the body

Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science framework to better understand how cells travel through the body.

23 Apr 2025

Varenicline found to help teens and young adults quit vaping

A new study by investigators from Mass General Brigham showed that teens and young adults who took varenicline-an FDA-approved, twice-daily smoking cessation pill for adults-are more than three times as likely to successfully quit vaping compared to those who received only behavioral counseling. Results are published in JAMA.

23 Apr 2025

Hyperbaric oxygen therapy brings long-term relief after cancer radiation

Hyperbaric oxygen treatment provides long-term relief for patients suffering from late radiation-induced injuries after treatment of cancer in the lower abdominal area.

23 Apr 2025